Cancer Biology Group - JNU, led by Prof. Rana P. Singh at the School of Life Sciences, Jawaharlal Nehru University (JNU), New Delhi, specializes in pioneering research in cancer biology and therapeutic strategies. The lab focuses on unraveling the molecular mechanisms underlying cancer initiation, progression, and metastasis, employing a multidisciplinary approach that includes molecular biology, oxidative stress biology, cell signaling, tumor angiogenesis, and experimental therapeutics.

Key research areas involve investigating non-toxic, natural phytochemicals as potential anticancer agents, particularly emphasizing their chemopreventive and therapeutic properties. Utilizing advanced experimental platforms like in vitro cell cultures, in vivo animal models, and genetically amenable Drosophila melanogaster models, the lab seeks to identify pathways involved in oxidative stress regulation, apoptosis, angiogenesis, and immune modulation.

Prof. Singh also directs the Drug and Pharmaceuticals Research Program (DPRP) at JNU and leads the Center for Excellence in Ayurveda and Systems Medicine, which promotes integrative research combining traditional Ayurveda with modern biomedical sciences.

RPS Cancer Lab collaborates internationally, notably contributing to the establishment of the "Centre for Integrative Cancer Biology and Therapeutics" alongside institutions such as Stanford University and Oregon Health & Science University. Committed to translational research, the lab aims to develop safer, effective, and personalized cancer therapies.

Prof. Singh is currently serving as the Vice Chancellor of Gautam Buddha University, Greater Noida, Delhi NCR. He also supervises the research work in his laboratory at JNU.